Someone on this forum said earlier today that they couldn't find any negatives in the report. If that's not looking through rose coloured glasses, then I don't know what is.
Maybe I should help out:
It sounds to me like the company has very low expectations?
- Deteriorating grades - from 1.27 to 1.11 - but the company said this was "in line with expectations for the quarter"
- Spodumene concentrate 15% lower than the previous quarter - from 52.1dmt to 44.2dmt - but the company said this was "slightly above expectation for the quarter"
- Unit cost per tonne mined up by 28% - from US$325 to US$415
![]()
- Forums
- ASX - By Stock
- GXY
- Ann: Quarterly Report - March 2018
Ann: Quarterly Report - March 2018, page-140
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add GXY (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online